EditForce Inc

EditForce, Inc. develops biotechnology solutions for gene editing and drug discovery. The Company focuses on research and development of RNA-targeted therapies for CNS, muscular, and rare diseases, and licenses proprietary PPR Platform Technology. EditForce Inc serves pharmaceutical companies and patients in Europe, Japan, and the United States.